Related Experiment Video
Updated: Jan 13, 2026

Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
Published on: April 7, 2023
Postbiotic Potential of Heat-Killed Lacticaseibacillus paracasei HP7 in Functional Dyspepsia
Daehyeop Lee1, Ji-Woong Jeong1, Joo-Yun Kim1
1R&BD Center, hy Co., Ltd., Yongin-si 17086, Gyeonggi-do, Republic of Korea.
Abstract:
Functional dyspepsia (FD) is a complex gastrointestinal disorder involving impaired motility and digestive dysfunction. This study investigated the postbiotic potential of heat-killed Lacticaseibacillus paracasei HP7 (HP7) in a loperamide-induced FD mouse model. Oral administration of heat-killed HP7 improved gastric emptying, and upregulated expression of genes related to smooth muscle contraction. Heat-killed HP7 treatment also modulated key gastrointestinal hormones, including gastrin (GAS), glucose-dependent insulinotropic peptide (GIP), and peptide YY (PYY), and restored the activities of digestive enzymes such as amylase and trypsin. To investigate potential mechanisms, heat-killed HP7 and exopolysaccharides (EPS) and surface-layer proteins (SLPs) derived from HP7 were applied to LPS-treated Caco-2 cells. These functional components strengthened epithelial barrier function by upregulating tight junction-related genes and reducing the expression of inflammatory genes. These results suggest that heat-killed HP7 and its functional cell surface molecules promoted gastric motility, strengthened barrier integrity, and mitigated inflammation through complementary pathways, indicating their potential as safe and effective postbiotic interventions for managing FD.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Drugs for Treatment of Constipation-Predominant IBS

